Zeng Xiaoru, Chen Ling, Chandra Ayush, Zhao Lin, Ma Guanglong, Roldan Francisco-Javier, Wei Hongquan, Pan Wanling, Li Wanquan
Internal Medicine-Cardiovascular Department, Foshan Sanshui District People's Hospital, Foshan, Guangdong, China.
Department of Clinical Medicine, Tianjin Medical University, Tianjin, China.
Front Cardiovasc Med. 2025 Mar 31;12:1509365. doi: 10.3389/fcvm.2025.1509365. eCollection 2025.
This narrative review aims to evaluate strategies for reducing door-to-balloon (D2B) time in ST-elevation myocardial infarction (STEMI) patients, focusing on pre-hospital, in-hospital, and technological innovations, as well as addressing challenges to ensure sustainability. We reviewed recent literature from 2004 onward, examining various approaches to streamline STEMI care and improve D2B time. The review encompasses pre-hospital interventions such as advanced ECG monitoring and pre-hospital alerts, in-hospital strategies such as standardized protocols and streamlined processes, and technological innovations such as automated ECG interpretation, mobile applications, and telemedicine. Pre-hospital strategies have demonstrated significant benefits in reducing D2B times through early diagnosis and rapid communication. In-hospital approaches, including the use of clinical pathways and decision support systems, contribute to minimizing delays and enhancing coordination among healthcare providers. Technological innovations, such as automated ECG systems and telemedicine, facilitate quicker diagnosis and treatment initiation. However, challenges such as resource limitations, staff turnover, and variability in care processes persist. Addressing these challenges through continuous quality improvement, standardized care protocols, and data-driven analytics is crucial for sustaining improvements. Effective reduction in D2B time in STEMI care requires a multifaceted approach involving pre-hospital and in-hospital strategies, as well as leveraging technological advancements. Overcoming challenges and ensuring sustainability demands ongoing commitment to quality improvement, resource management, and standardized protocols. By integrating these strategies, healthcare systems can enhance the timeliness of STEMI care and improve patient outcomes.
本叙述性综述旨在评估降低ST段抬高型心肌梗死(STEMI)患者门球时间(D2B)的策略,重点关注院前、院内及技术创新方面,并应对相关挑战以确保可持续性。我们回顾了2004年以来的近期文献,研究了简化STEMI治疗流程及缩短D2B时间的各种方法。该综述涵盖院前干预措施,如高级心电图监测和院前警报;院内策略,如标准化方案和简化流程;以及技术创新,如自动心电图解读、移动应用程序和远程医疗。院前策略已证明通过早期诊断和快速沟通在缩短D2B时间方面具有显著益处。院内方法,包括使用临床路径和决策支持系统,有助于减少延误并加强医疗服务提供者之间的协调。技术创新,如自动心电图系统和远程医疗,有助于更快地进行诊断和开始治疗。然而,资源限制、人员更替和护理流程差异等挑战依然存在。通过持续质量改进、标准化护理方案和数据驱动的分析来应对这些挑战对于维持改进至关重要。有效缩短STEMI治疗中的D2B时间需要采取多方面方法,包括院前和院内策略,以及利用技术进步。克服挑战并确保可持续性需要持续致力于质量改进、资源管理和标准化方案。通过整合这些策略,医疗系统可以提高STEMI治疗的及时性并改善患者预后。